Kevin Lara
Family · Delray Beach, FLNPI 1396266896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,142 and has fallen 75.7% since, to $277 in 2025.
Across 132 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$260
- GSK$238
- Lilly USA, LLC$236
- AbbVie$171
- Exact Sciences$164
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$129
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,557100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $260 |
| GSK | 12 | $238 |
| Lilly USA, LLC | 14 | $236 |
| AbbVie | 9 | $171 |
| Exact Sciences | 9 | $164 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $129 |
| Merck | 7 | $127 |
| AstraZeneca | 7 | $123 |
| Astellas Pharma US Inc | 5 | $105 |
| Abbott | 6 | $100 |
| Boehringer Ingelheim | 4 | $84 |
| Sunovion Pharmaceuticals Inc. | 4 | $84 |
| Pfizer | 4 | $78 |
| Saluda Medical Americas, Inc. | 2 | $75 |
| Gilead | 4 | $74 |
| Jazz Pharmaceuticals Inc. | 4 | $67 |
| Johnson & Johnson | 4 | $67 |
| Boston Scientific | 2 | $54 |
| Spinal Simplicity, LLC | 1 | $51 |
| Amarin Pharma, Inc. | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Novartis | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Bayer | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Medtronic | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
How this compares
$2,557 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 14 | $836 |
| Levothyroxine Sodium | 60 | $675 |
| Atorvastatin Calcium | 88 | $657 |
| Duloxetine Hcl | 25 | $607 |
| Azelastine Hcl | 28 | $549 |
| Losartan Potassium | 57 | $480 |
| Ciclopirox | 16 | $395 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 37 | $361 |
| Metoprolol Succinate | 25 | $351 |
| Rosuvastatin Calcium | 42 | $351 |
| Omeprazole | 29 | $317 |
| Nifedipine ErNifedipine | 14 | $247 |
| Gabapentin | 24 | $238 |
| Hydralazine Hcl | 13 | $215 |
| Amlodipine Besylate | 64 | $212 |
Paid to pharmacies, not to this prescriber.
Other family in Delray Beach
- Basya NachlasDelray Beach$48K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.